Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)

被引:0
|
作者
D'Souza, Ninoschka C.
Aleali, Nadia
Shakeri, Dorsa
Hoffman, Emily G.
Atherley, Sara C.
Champsi, Sabrina
El-Zahed, Maya
Liggins, Richard
Chan, Owen
Riddell, Michael C.
机构
关键词
D O I
10.2337/db23-2-LB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2-LB
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Duodenal Targeting by Oral Pharmacologic Duodenal Exclusion Therapy for Treatment of Type 2 Diabetes (T2D)
    Nimgaonkar, Ashish
    Bryant, Christine
    Carlson, Taylor
    Guerina, Florence V.
    Colbert, Kevin
    Polomoscanik, Steven
    Petersen, John S.
    Jozefiak, Thomas H.
    Fineman, Mark
    DIABETES, 2023, 72
  • [32] Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes
    Erwan Leclair
    Richard T. Liggins
    Ashley J. Peckett
    Trevor Teich
    David H. Coy
    Mladen Vranic
    Michael C. Riddell
    Diabetologia, 2016, 59 : 1724 - 1731
  • [33] Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes
    Leclair, Erwan
    Liggins, Richard T.
    Peckett, Ashley J.
    Teich, Trevor
    Coy, David H.
    Vranic, Mladen
    Riddell, Michael C.
    DIABETOLOGIA, 2016, 59 (08) : 1724 - 1731
  • [34] A microplate binding assay for the somatostatin type-2 receptor (SSTR2)
    Froidevaux, S
    Meier, M
    Häusler, M
    Mäcke, H
    Beglinger, C
    Eberle, AN
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (1-4): : 167 - 180
  • [35] Sex differences in the influence of type 2 diabetes (T2D)-related genes, parental history of T2D, and obesity on T2D development: a case-control study
    Berumen, Jaime
    Orozco, Lorena
    Gallardo-Rincon, Hector
    Rivas, Fernando
    Barrera, Elizabeth
    Benuto, Rosa E.
    Garcia-Ortiz, Humberto
    Marin-Medina, Melissa
    Juarez-Torres, Eligia
    Alvarado-Silva, Anabel
    Ramos-Martinez, Espiridion
    Martinez-Juarez, Luis Alberto
    Lomelin-Gascon, Julieta
    Montoya, Alejandra
    Ortega-Montiel, Janinne
    Alvarez-Hernandez, Diego-Abelardo
    Larriva-Shad, Jorge
    Tapia-Conyer, Roberto
    BIOLOGY OF SEX DIFFERENCES, 2023, 14 (01)
  • [36] Comparing a Somatostatin Receptor 2 Antagonist (SSTR2a) to Exogenous Glucagon (EG) for the Treatment of Severe Insulin-Induced Hypoglycemia
    Hoffman, Emily G.
    Dsouza, Ninoschka
    Aleali, Nadia
    Nozariasbmarz, Newsha
    Fatehi, Samaneh
    Shakeri, Dorsa
    Chan, Owen
    Liggins, Richard
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [37] Effect of Type 2 Diabetes (T2D) on the Nocturnal Pattern of Change of Endogenous Glucose Production, Glycogenolysis (GGL), and Gluconeogenesis (GNG)
    Basu, Rita
    Carter, Rickey
    Mcconahey, Brent
    Schwichtenberg, Prestin
    Rizza, Robert A.
    Basu, Ananda
    DIABETES, 2017, 66 : A91 - A91
  • [38] β-Cell Function, Incretin Hormones, and Incretin Effect in Obese Youth along the Span of Glucose Tolerance from Normal to Prediabetes to Type 2 Diabetes (T2D)
    Michaliszyn, Sara
    Lee, Sojung
    Bacha, Fida
    Tfayli, Hala
    Farchoukh, Lama
    Mari, Andrea
    Ferrannini, Ele
    Arslanian, Silva A.
    DIABETES, 2014, 63 : A43 - A43
  • [39] Adipocyte Insulin Resistance Index in Youth along the Span of Glycemia from Normal Glucose Tolerance (NGT) to Impaired Glucose Tolerance (IGT) to Type 2 Diabetes (T2D)
    Kim, Joon Young
    Bacha, Fida
    Tfayli, Hala
    Michaliszyn, Sara
    Arslanian, Silva A.
    DIABETES, 2018, 67
  • [40] NMR-Determined Lipoprotein Subpopulation Distribution in Obese Women with Normoglycemia, Impaired Glucose Tolerance (IGT) and Type 2 Diabetes (T2D)
    Barakat, Hisham
    Tanenberg, Robert
    Holbert, Don
    OBESITY, 2008, 16 : S171 - S171